Clinical Trial Update: Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding study of BMS-955176 in treatment-naive adults with HIV-1 was terminated; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• BMS-955176

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 2 | Status: TERMINATED | Results posted: 2018-09-19